HopeStage
Back to overview

Depression studies

Topics
More filters

Depression

Depression involves persistent low mood or loss of interest, often with tiredness and changes in sleep or appetite.

7264studies shown
Showing 2,077-2,088 of 7,264
Drug study icon
CompletedNCT02133001

Intranasal Esketamine for depression

What is this study about?

This study evaluated the safety and effectiveness of Esketamine for people with depression.

This study has finished and is no longer accepting participants.

Multiple locations, including Birmingham
Depression, SuicidalityMedication studyAges 18–64
Countries
United States
Sponsor
Janssen Research & Development, LLC
Behavioral study icon
CompletedNCT06981000

Feasibility of nature-based groups for anxiety, depression and stress

About this title

A Feasibility Study of Nature-based Health Interventions for People With Mild to Moderate Anxiety, Depression and Stress

Read the official source — NCT06981000
Official study title

A Feasibility Study of Locally Adapted Nature-based Health Interventions for People With Mild to Moderate Anxiety, Depression and Stress

This study has finished and is no longer accepting participants.

In Copenhagen
Depression, AnxietyBehavioural studyAges 18+
Countries
Denmark
Sponsor
University of Copenhagen
Behavioral study icon
CompletedNCT06856668

A Megastudy of Single-Session Interventions for Depression

Official study title

A Megastudy of Single-Session Interventions to Challenge Depression in American Adults

This study has finished and is no longer accepting participants.

In Chicago
DepressionBehavioural studyAges 18+
Countries
United States
Sponsor
Northwestern University
Drug study icon
Active Not RecruitingNCT06941844

Study of DT120 for Major Depressive Disorder (Emerge)

What is this study about?

Researchers are comparing DT120 and placebo to find out how the approaches affect depression symptoms in adults with depression.

This study is no longer accepting new participants.

Multiple locations, including Little Rock
DepressionMedication studyAges 18–74
Countries
United States
Sponsor
Definium Therapeutics US, Inc.
Drug study icon
Active Not RecruitingNCT05733546

A Phase II, Multicentre, Controlled Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of COMP360 in people with Recurrent Major Depressive Disorder

Official study title

A Phase II, Multicentre, Randomised, Double-blind, Controlled Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of COMP360 in Participants With Recurrent Major Depressive Disorder

This study is no longer accepting new participants.

Multiple locations, including La Jolla
DepressionMedication studyAges 18+
Countries
United States
Sponsor
COMPASS Pathways
Drug study icon
CompletedNCT00377299

Citicoline add-on Therapy for depression

Official study title

A Double-blind, Placebo-controlled Pilot Study of Citicoline add-on Therapy in Patients With Bipolar Disorder or Major Depressive Disorder and Amphetamine Abuse or Dependence

This study has finished and is no longer accepting participants.

In Dallas
Depression, BipolarityMedication studyAges 18–70
Countries
United States
Sponsor
University of Texas Southwestern Medical Center
Other study type icon
CompletedNCT03774641

A Study of Prophylactic Management of Lamotrigine in Pregnant Women

Official study title

A Pilot Study of Prophylactic Management of Lamotrigine for Bipolar Disorder in Pregnant Women

This study has finished and is no longer accepting participants.

In Baltimore
Depression, BipolarityObservational studyAges 18+
Countries
United States
Sponsor
Johns Hopkins University

Registry coverage

We gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.